XML 70 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Acquisition of CryoGene Partners - Pro Forma Information (Details)
$ / shares in Units, € in Millions
 12 Months Ended
Oct. 01, 2020
EUR (€)
Oct. 01, 2020
USD ($)
May 14, 2019
USD ($)
May 04, 2019
USD ($)
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2019
USD ($)
$ / shares
Business Acquisition [Line Items]            
Revenues         $ 172,147,000 $ 163,217,000
Net loss         $ (18,562,000) $ (3,149,000)
Basic and diluted net loss per share | $ / shares         $ (2.08) $ (0.09)
CryoGene Partners [Member]            
Business Acquisition [Line Items]            
Revenues         $ 3,000,000.0 $ 3,000,000.0
Net loss         437,100 437,100
Total purchase consideration paid     $ 20,317,000 $ 20,300,000    
CRYOPDP            
Business Acquisition [Line Items]            
Revenues         12,900,000  
Net loss         1,800,000  
Total purchase consideration paid € 48.3 $ 56,971,000        
MVE            
Business Acquisition [Line Items]            
Elimination of revenue           1,800,000
Elimination of cost of goods sold           $ 900,000
Revenues         23,000,000.0  
Net loss         $ 1,800,000  
Total purchase consideration paid   $ 317,470,000